pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
◐
Sign In
Subscribe
🐶
home
jobs
news
search
the cabinet
Drugs
8,127
products tracked
★ save view
↓
export CSV
search
phase
all
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
sort
catalysts
recent
name
therapeutic area
all
Oncology
1831
Infectious Disease
718
Cardiology
425
Pulmonology
396
Immunology
371
Ophthalmology
368
Dermatology
300
Women's Health
view
list
cards
Phase 2
Jankistomig
Solid Tumor
Ottimo Pharma Ltd
0
catalysts
Phase 3
JointStem
Osteoarthritis
Biostar Stem Cell Research Institute
0
catalysts
Phase 3
Jynneos
Smallpox
Bavarian Nordic AS
0
catalysts
Preclinical
K-130
Neurogenic Orthostatic Hypotension (nOH)
← prev
page 113 of 271
next →
131
Pain
89
Neurology
1
$AMRX
Amneal Pharmaceuticals, Inc.
0
catalysts
Phase 3
K-161
Keratoconjunctivitis Sicca (Dry Eye)
Kowa Co Ltd
0
catalysts
Phase 1
KA-34
Osteoarthritis
California Institute for Biomedical Research
0
catalysts
KADCYLA
KADCYLA (ADO-TRASTUZUMAB EMTANSINE)
Genentech Inc
0
catalysts
KALYDECO
KALYDECO (IVACAFTOR)
1 INDICATIONS AND USAGE KALYDECO is indicated for the treatment of cystic fib…
Cystic fibrosis transmembrane conductance regulator
$VERX
Vertex, Inc.
0
catalysts
KANJINTI
KANJINTI (TRASTUZUMAB-ANNS)
$AMGN
AMGEN INC
0
catalysts
Phase 1
KB-407
Cystic Fibrosis
$KRYS
Krystal Biotech, Inc.
0
catalysts
Phase 1
KB-408
Alpha-1 Antitrypsin Deficiency (A1AD)
$KRYS
Krystal Biotech, Inc.
0
catalysts
Phase 2
KB-707
Metastatic Melanoma
$KRYS
Krystal Biotech, Inc.
0
catalysts
Phase 2
KB-801
Neurotrophic Keratitis
$KRYS
Krystal Biotech, Inc.
0
catalysts
Phase 2
KBLP-001
Plaque Psoriasis (Psoriasis Vulgaris)
KoBioLabs Inc
0
catalysts
Phase 1
KBLP-002
Asthma
KoBioLabs Inc
0
catalysts
Preclinical
KBX-114
Gynecological Cancer
Kaida BioPharma Inc
0
catalysts
Phase 1
KER-0193
Fragile X Syndrome
Kaerus Bioscience Ltd
0
catalysts
Preclinical
KET-003
ketamine [INN]
Amyotrophic Lateral Sclerosis
PharmaTher Holdings Ltd
0
catalysts
Preclinical
KET-101
ketamine [INN]
Pain
PharmaTher Holdings Ltd
0
catalysts
Phase 2
KETAMINE HYDROCHLORIDE
KETAMINE HYDROCHLORIDE (KETAMINE HYDROCHLORIDE)
Major Depressive Disorder
Glutamate [NMDA] receptor
Seelos Therapeutics, Inc.
0
catalysts
Phase 3
KETOROLAC TROMETHAMINE
KETOROLAC TROMETHAMINE (KETOROLAC TROMETHAMINE)
Post-Operative Pain
Cyclooxygenase
Neumentum Inc
0
catalysts
KEYTRUDA
KEYTRUDA (PEMBROLIZUMAB)
Merck Sharp & Dohme LLC
0
catalysts
KEYTRUDA QLEX
KEYTRUDA QLEX (PEMBROLIZUMAB)
Merck Sharp & Dohme LLC
0
catalysts
Preclinical
KFPH-013
Unspecified Cancer
Jiangsu Carephar Pharmaceutical Co Ltd
0
catalysts
Preclinical
KFPH-015
Influenzavirus A Infections
Jiangsu Carephar Pharmaceutical Co Ltd
0
catalysts
Preclinical
KFPH-020
Hypercholesterolemia
Jiangsu Carephar Pharmaceutical Co Ltd
0
catalysts
Phase 1
KGX-101
Solid Tumor
Shanghai KangaBio Co Ltd
0
catalysts
Preclinical
KIN-102
Solid Tumor
Kinimmune Inc
0
catalysts
Phase 1
KINE-101A
Rheumatoid Arthritis
Kine Sciences
0
catalysts
KISQALI FEMARA CO-PACK
KISQALI FEMARA CO-PACK (LETROZOLE AND RIBOCICLIB)
NOVARTIS
0
catalysts
